The histone deacetylase inhibitor Romidepsin induces as a cascade of differential gene expression and altered histone H3K9 marks in myeloid leukaemia cells

Myelodysplastic syndromes (MDS) are a heterogeneous, clonal haematopoietic disorder, with ~1/3 of patients progressing to acute myeloid leukaemia (AML). Many elderly MDS patients do not tolerate intensive therapeutic regimens, and therefore have an unmet need for better tolerated therapies. Epigenet...

Descripción completa

Detalles Bibliográficos
Autores principales: Clarke, Kathryn, Young, Christine, Liberante, Fabio, McMullin, Mary-Frances, Thompson, Alexander, Mills, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544403/
https://www.ncbi.nlm.nih.gov/pubmed/31191819
http://dx.doi.org/10.18632/oncotarget.26877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544403/
https://www.ncbi.nlm.nih.gov/pubmed/31191819
http://dx.doi.org/10.18632/oncotarget.26877

Ejemplares similares